Literature DB >> 25422089

Interferon regulatory factor 7 participates in the M1-like microglial polarization switch.

Tatsuhide Tanaka1, Koichi Murakami, Yoshio Bando, Shigetaka Yoshida.   

Abstract

Microglia are generally considered the immune cells of the central nervous system. Recent studies have demonstrated that under specific polarization conditions, microglia develop into two different phenotypes, termed M1-like and M2-like microglia. However, the phenotypic characteristics of M1-like- and M2-like-polarized microglia and the mechanisms that regulate polarization are largely unknown. In this study, we characterized lipopolysaccharide-treated M1-like and IL-4-treated M2-like microglia and investigated the mechanisms that regulate phenotypic switching. The addition of M2-like microglial conditioned medium (CM) to primary neurons resulted in an increase in neurite length when compared with neurons treated with M1-like microglial CM, possibly because of the enhanced secretion of neurotrophic factors by M2-like microglia. M1-like microglia were morphologically characterized by larger soma, whereas M2-like microglia were characterized by long processes. M2-like microglia exhibited greater phagocytic capacity than M1-like microglia. These features switched in response to polarization cues. We found that expression of interferon regulatory factor 7 (IRF7) increased during the M2-like to M1-like switch in microglia in vitro and in vivo. Knockdown of IRF7 using siRNA suppressed the expression of M1 marker mRNA and reduced phosphorylation of STAT1. Our findings suggest that IRF7 signaling may play an important role in microglial polarization switching.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  IRF7; M1; M2; microglia; polarization

Mesh:

Substances:

Year:  2014        PMID: 25422089     DOI: 10.1002/glia.22770

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  31 in total

Review 1.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

2.  TRAM1 Promotes Microglia M1 Polarization.

Authors:  Hanxiang Wang; Chun Liu; Ming Han; Chun Cheng; Dongmei Zhang
Journal:  J Mol Neurosci       Date:  2015-11-12       Impact factor: 3.444

Review 3.  Transcriptional control of microglia phenotypes in health and disease.

Authors:  Inge R Holtman; Dylan Skola; Christopher K Glass
Journal:  J Clin Invest       Date:  2017-07-31       Impact factor: 14.808

4.  Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration.

Authors:  James P Barrett; Rebecca J Henry; Kari Ann Shirey; Sarah J Doran; Oleg D Makarevich; Rodney M Ritzel; Victoria A Meadows; Stefanie N Vogel; Alan I Faden; Bogdan A Stoica; David J Loane
Journal:  J Neurosci       Date:  2020-02-06       Impact factor: 6.167

5.  Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.

Authors:  Taichi Nomura; Yoshio Bando; Hua You; Tatsuhide Tanaka; Shigetaka Yoshida
Journal:  Neurochem Res       Date:  2017-09-19       Impact factor: 3.996

Review 6.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

7.  Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Authors:  Hui-Ming Chen; William van der Touw; Yuan Shuo Wang; Kyeongah Kang; Sunny Mai; Jilu Zhang; Dayanira Alsina-Beauchamp; James A Duty; Sathish Kumar Mungamuri; Bin Zhang; Thomas Moran; Richard Flavell; Stuart Aaronson; Hong-Ming Hu; Hisashi Arase; Suresh Ramanathan; Raja Flores; Ping-Ying Pan; Shu-Hsia Chen
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

8.  Correction to: Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

9.  Repolarizing heterogeneous leukemia-associated macrophages with more M1 characteristics eliminates their pro-leukemic effects.

Authors:  Xiao Yang; Wenli Feng; Rong Wang; Feifei Yang; Lina Wang; Shayan Chen; Yongxin Ru; Tao Cheng; Guoguang Zheng
Journal:  Oncoimmunology       Date:  2017-12-26       Impact factor: 8.110

Review 10.  Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.

Authors:  Jun Tsuyama; Akari Nakamura; Hiroaki Ooboshi; Akihiko Yoshimura; Takashi Shichita
Journal:  Semin Immunopathol       Date:  2018-09-11       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.